Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150433 · ClinicalTrials.gov registry record · NA
Sleep and Pain in Sickle Cell Disease
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT03150433: Completed NA study, sponsored by Johns Hopkins University.
NCT03150433 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03150433, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
This is a study testing the effects of behavioral sleep interventions on pain and brain function in sickle cell disease.
Primary Outcome
Average of 4 items from the Brief Pain Inventory; each rated on a 0 (no pain) to 10 (pain as bad as you can imagine); ratings are made of pain right now, typical pain, worst pain, and least pain during the past week. Total sub-score of 0-40 with higher score indicating more pain.
Interventions
- BEHAVIORAL Behavioral symptom management
- OTHER Sickle cell disease management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2017-11-05 |
| Est. Completion | 2023-10-27 |
| Phase | NA |
What the finished NCT03150433 record still lists
NCT03150433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral symptom management is the first listed.
NCT03150433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03150433 about?
NCT03150433 is a clinical study titled "Sleep and Pain in Sickle Cell Disease". This is a study testing the effects of behavioral sleep interventions on pain and brain function in sickle cell disease.
What is the current status of trial NCT03150433?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2017-11-05. Estimated completion is 2023-10-27.
What interventions are being tested in trial NCT03150433?
The interventions under investigation include: Behavioral symptom management (BEHAVIORAL), Sickle cell disease management (OTHER).
Who is sponsoring clinical trial NCT03150433?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03150433's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI